BackKodiak Sciences Overview
Kodiak Sciences Inc

Kodiak Sciences Target Price

See Kodiak Sciences's analyst price targets ($93) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$94.45

Average Target Price

$93.401.1% downside

5 analysts in the last 4 months

High: $120 | Low: $36

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-30Goldman SachsAndrea Newkirk$1039.1% upsideOpen
2026-09-29UBSMichael Yee$12027.1% upsideOpen
2026-09-28Jefferies$11218.6% upsideOpen
2026-09-28H.C. WainwrightMatthew Caufield$961.6% upsideOpen
2026-09-24Goldman Sachs$3661.9% downsideOpen
2026-05-11Chardan Capital$6135.4% downsideOpen
2026-03-27UBS$8015.3% downsideOpen
2026-03-27H.C. WainwrightMatthew Caufield$5838.6% downsideOpen
2026-03-26Jefferies$5640.7% downsideOpen
2026-01-22H.C. WainwrightMatthew Caufield$3859.8% downsideOpen
2026-01-07UBSMichael Yee$5047.1% downsideOpen
2025-09-25BarclaysGena Wang$1782% downsideOpen
2024-12-09JefferiesMichael Yee$2078.8% downsideOpen
2024-09-24Goldman SachsAndrea Tan$297.9% downsideOpen
2022-11-14Morgan Stanley$990.5% downsideOpen
2022-11-10Goldman Sachs$891.5% downsideOpen
2022-08-15Morgan Stanley$1287.3% downsideOpen
2022-08-10Chardan Capital$1880.9% downsideOpen
2022-08-09Truist Financial$1584.1% downsideOpen
2022-08-09Goldman Sachs$990.5% downsideOpen
2022-05-24Goldman Sachs$594.7% downsideOpen
2022-05-11Goldman Sachs$792.6% downsideOpen
2022-02-11Goldman SachsAndrea Tan$7025.9% downsideOpen
2021-11-12BMO CapitalMatthew Luchini$11420.7% upsideOpen

Kodiak Sciences (KOD) FAQ

Kodiak Sciences's target price stands at $93. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $93 for KOD implies 1.1% downside versus today's price ($94.45). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Kodiak Sciences's target price evolved across reporting periods, while the comparison chart places KOD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Kodiak Sciences's reading of $93 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.